Millennium Management bought a stake in Acurx Pharmaceuticals, which is headquartered in King of Prussia and trades on the Nasdaq stock exchange.
3 reports, 1 independent
Updated Aug 14
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Millennium Management bought a stake in Acurx Pharmaceuticals, which is headquartered in King of Prussia and trades on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Millennium Management
alternative investment management firm
- Millennium Management is establishing a presence in Athens, the capital of Greece, while Kyriakos Mitsotakis serves as Prime Minister and Kyriakos Pierrakakis discusses expansion.
- Millennium Management, specializing in Japanese government bonds, faced adverse strategy impacts due to yen rate volatility and filed regulatory records with the Monetary Authority of Singapore.
-
Nasdaq
American fully electronic stock exchange
Related events
- Acurx Pharmaceuticals trades on NASDAQ and is receiving FDA guidance supporting its potential approval pathway.
- Millennium Management purchased shares of SpaceX.
- AC Immune, headquartered in Lausanne, Switzerland, is a company that trades on the Nasdaq exchange and maintains a subsidiary in Boston.
- Millennium Management increased its stake in AbbVie and purchased shares of SpaceX stock on September 12, 2026.
- Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.